Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 5, 1999, Pages 1518-1523

  Colao, Annamaria ^a   Cuocolo, Alberto ^a   Marzullo, Paolo ^a   Nicolai, Emanuele ^a   Ferone, Diego ^a   Della Morte, Anna Maria ^a   Petretta, Mario ^a   Salvatore, Marco ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART PERFORMANCE; HEART SCINTISCANNING; HEART STROKE VOLUME; HUMAN; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0033324252     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.5.5674     Document Type: Article

References (32)

1. Epidemiology of acromegaly in the Newcastle region
2. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984
3. Determinants of clinical outcome and survival in acromegaly
4. Growth hormone and the heart
5. Heart muscle disease in acromegaly
6. Echocardiographic assessment of cardiac anatomy and function in acromegalic patient
7. Cardiac hypertrophy and function in asymptomatic acromegaly
8. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study
9. Impaired left ventricular diastolic function in acromegaly: An echocardiographic study
10. Subclinical cardiac dysfunction in acromegaly: Evidence for a specific disease of heart muscle
11. Acromegalic cardiopathy: A left ventricular scintigraphic study
12. Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension
13. Is growth hormone bad for your heart: Cardiovascular impact of GH deficiency and excess
14. Acromegaly
15. Effect of growth hormone on cardiac function
16. Cardiological aspects of growth hormone and insulin-like growth factor-1
17. Left ventricular diastolic filling and its association with age
18. Effects of aging on asynchronous left ventricular regional function and global ventricular filling in normal human subjects
19. Prediction of efficacy of octreotide therapy in patients with acromegaly
20. Cardiovascular aspects in acromegaly: Effects of treatment
21. Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography
22. Left ventricular peak ejection rate, filling rate and ejection fraction: Frame requirements at rest and exercise
23. Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: Reversal after coronary angioplasty
24. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly
25. Impaired left ventricular diastolic filling in patients with acromegaly: Assessment with radionuclide angiography
26. The cardiovascular effects of octreotide treatment in acromegaly: An echocardiographic study
27. Acromegalic cardiopathy improves after treatment with increasing doses of octreotide
28. Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly
29. Cardiovascular effects of the somatostatin analog octreotide in acromegaly
30. Effects of one year treatment with octreotide on cardiac performance in acromegaly
31. Growth hormone and prolactin excess